Three things to know:
1. The company plans to use the funds to accelerate the launch of its Zap-X surgical robot for the treatment of brain cancer and other disorders.
2. Zap-X provides image-guided stereotactic radiosurgery for tumors, lesions and conditions of the brain, head and neck, according to the company’s website.
3. More than $160 million has been raised by Zap Surgical in financing capital since it was founded in 2014.
More articles on devices:
Dr. Bryan Little appointed to state medical board, task force
Former Medtronic, Bioventus executive becomes CEO at BlueWind Medical
Exactech co-founders retire, current CEO to transition to board role — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.